VASCULAR BIOGENICS LTD (VBLT) Stock Analyst Ratings
NASDAQ:VBLT - Nasdaq - IL0011327454 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 46% to VBLT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.1. This target is 3169.23% above the current price.
VBLT was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about VBLT.
In the previous month the buy percentage consensus was at a similar level.
VBLT was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-07-21 | Chardan Capital | Downgrade | Buy -> Neutral |
| 2022-07-20 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-04-28 | Chardan Capital | Initiate | Buy |
| 2021-06-03 | Roth Capital | Maintains | Buy |